Eva Live Inc
Filed Jul 11, 2025.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Jul 11, 2025
Contents
Cover page
Show cover page
As filed** with the U.S. Securities and Exchange Commission on July 11, 2025.**
Registration No. ________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORMS-1
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
(Exact name of registrant as specified in its charter)
| Nevada | 7370 | 88-2864075 |
|---|---|---|
| (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer |
| incorporation or organization) | Classification Code Number) | Identification Number) |
The Plaza,1800 Century Park East, Suite 600
Los Angeles, CA 90067
Tel:(310) 229-5981
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Nevada Agency And Transfer Company
50 West Liberty Street, Suite 880,
Reno, NV,89501, USA
Tel:(775) 322-0626
(Name, address, including zip code, and telephone number, including area code, of agent for service)
With copies to:
| Marc Ross, Esq. Avital Perlman, Esq. Sichenzia Ross Ference Carmel LLP 1185 Avenue of the Americas, 31st Floor New York, NY 10036 Telephone: (212) 930-9700 Fax: (212)930-9725 | M. Ali Panjwani, Esq. Pryor Cashman LLP 7 Times Square, 40th Floor New York, NY 10036 (212) 421-4100 Telephone: (212) 421-4100 Fax: (212) 326-0806 |
|---|
Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement (“Registration Statement”) is declared effective.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box: ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | Accelerated filer ☐ |
|---|---|
| Non-accelerated filer ☒ | Smaller reporting company ☒ |
| Emerging growth company ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act.☐
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the U.S. Securities and Exchange Commission, acting pursuant to Section 8(a), may determine.
The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the U.S. Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED JULY 11, 2025
PRELIMINARY PROSPECTUS
2,500,000** Units**
Each Unit Consisting of
One Share of Common Stock and
One Warrant to Purchase One Share of Common Stock
We are offering our securities at a public offering price of $4.00 per Unit (as defined below).
Each “Unit” consists of one share of our common stock and one warrant (each, a “Warrant”, and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of at least $[ ] per share. The Units have no stand-alone rights and will not be certificated or issued as stand-alone securities. The shares of common stock and the Warrants comprising the Units are immediately separable and will be issued separately in this offering. Each Warrant offered hereby is immediately exercisable on the date of issuance and will expire five years from the date of issuance.
Prior to this offering, our common stock was quoted on the OTCQB Marketplace (the “OTCQB”) under the symbol “GOAI.” There is no established trading market for the Warrants. We intend to apply for listing of our common stock and Warrants on the NASDAQ Capital Market (“Nasdaq”) under the symbols “GOAI” and “GOAIW”, respectively. We believe that upon the completion of the offering contemplated by this prospectus, we will meet the standards for listing on Nasdaq.
There is no assurance that our common stock or Warrants will be approved for listing on Nasdaq. If our common stock or Warrants are not approved for listing, this offering will not proceed.
The last reported sale price for our common stock as reported on the OTCQB on [ ], 2025 was $[ ]. The offering price of the Units has been determined by negotiations between the underwriters and us considering our historical performance and capital structure, prevailing market conditions, and overall assessment of our business, and may be at a discount to the current market price. The prices at which our common stock was quoted on the OTCQB may not be indicative of the actual public offering price for our Units or of the prices at which our common stock may trade on Nasdaq in the future.
Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 9 of this prospectus for a discussion of information that you should consider before investing in our securities. Unless otherwise noted, the share and per share information in this prospectus and the financial statements and notes included herein reflects our February 4, 2025 reverse stock split of the outstanding common stock at a 1-for-4 ratio.
We are an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended, and we have elected to comply with certain reduced public company reporting requirements.
Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| Per Unit | Total | ||
| Price to the public | $ | $ | |
|---|---|---|---|
| Underwriting discounts and commissions (1) | $ | $ | |
| Proceeds to us (before expenses) (2) | $ | $ |
| (1) | We have agreed to provide to the underwriter an underwriting discount of seven percent (7.0%) of such public offering. We have also agreed to issue warrants to purchase shares of our common stock to the underwriter (the “Underwriter’s Warrants”, each, a “Underwriter’s Warrant”) and to reimburse the underwriter for certain expenses. The Underwriter’s Warrants are exercisable for a number of shares of common stock equal to 7.0% of the number of Units sold in this offering, at an exercise price equal to 125% of the public offering price per Unit. See “Underwriting” for additional information regarding total underwriter compensation. |
| (2) | The amount of offering proceeds to us presented in this table does not give effect to any exercise of the: (i) over-allotment option (if any) we have granted to the underwriter as described below and (ii) warrants being issued to the underwriter in this offering. |
We have granted a 45-day option to the underwriter to purchase up to an additional [ ] Units solely to cover overallotments, if any, at the public offering price, less underwriting discounts and commissions. If the representative of the underwriters exercises the option in full, the total underwriting discounts and commissions payable will be $_____ and the total proceeds to us, before expenses, will be $_____.
The underwriter expects to deliver the securities against payment to the investors in this offering made on or about _________ , 2025.
Sole Book-Running Manager
Maxim Group LLC
The date of this prospectus is _______________ , 2025.
TABLE OF CONTENTS
| PROSPECTUS SUMMARY | 3 |
|---|---|
| THE OFFERING | 8 |
| RISK FACTORS | 9 |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | 18 |
| USE OF PROCEEDS | 18 |
| DETERMINATION OF OFFERING PRICE | 19 |
| DIVIDEND POLICY | 19 |
| CAPITALIZATION | 19 |
| DILUTION | 20 |
| MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 22 |
| OUR BUSINESS | 28 |
| MANAGEMENT | 34 |
| EXECUTIVE COMPENSATION | 37 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 38 |
| CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS | 38 |
| DESCRIPTION OF SECURITIES | 38 |
| UNDERWRITING | 41 |
| LEGAL MATTERS | 45 |
| EXPERTS | 45 |
| WHERE YOU CAN FIND MORE INFORMATION | 46 |
| INDEX TO FINANCIAL STATEMENTS | F-1 |
Neither we nor the underwriters have authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses we have prepared. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may provide you. We are offering to sell, and seeking offers to buy, Units only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of the Units.
Neither we nor the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than the United States. You are required to inform yourself about, and to observe any restrictions relating to, this offering and the distribution of this prospectus.
MARKET, INDUSTRY AND OTHER DATA
This prospectus includes industry and market data that we obtained from periodic industry publications, third-party studies and surveys, filings of public companies in our industry and internal company surveys. These sources may include government and industry sources. Industry publications and surveys generally state that the information contained therein has been obtained from sources believed to be reliable. Although we believe the industry and market data to be reliable as of the date of this prospectus, this information could prove to be inaccurate. Industry and market data could be wrong because of the method by which sources obtained their data and because information cannot always be verified with complete certainty due to the limits on the availability and reliability of raw data, the voluntary nature of the data gathering process and other limitations and uncertainties. In addition, we do not know all of the assumptions regarding general economic conditions or growth that were used in preparing the forecasts from the sources relied upon or cited herein.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.